Skip to content

Survey study to investigate the preference of different amounts of 2 mm and 3 mm mini-tablets among children, parents and healthcare professionals.

Survey study to investigate the preference of different amounts of 2 mm and 3 mm mini-tablets among children, parents and healthcare professionals. - MiniMax

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032860
Enrollment
336
Registered
2023-10-13
Start date
2023-10-16
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All acutely and chronically sick patients, as well as parents and healthcare professionals.

Interventions

Group 1: This study has one arm where each participant is presented with all the mini tablets and answers all the questions.

Sponsors

Universitätsklinikum Düsseldorf, Klinik für Allgemeine Pädiatrie, Neonatologie und Kinderkardiologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age: Children aged 6-<12 y, adolescents aged 12-<18 y, parents of paediatric patients aged 0-<18 y, health care professionals (nurses and paediatricians) taking care of paediatric patients aged 0-<18 y 2. Sex: For paediatric patients only: male or female 3. Health: For paediatric patients only: acutely or chronically sick. For parents and health care professionals: taking care of acutely or chronically sick children/adolescents the definition by Mokkink LB et. al, a participant is considered to be chronically sick if the underlying disease or condition lasts 3 months or more or has occurred 3 times or more during the past year and will probably reoccur. It affects a child’s normal activities and requires frequent hospitalisations, home health care, and/or extensive medical care. The underlying disease or condition is not (yet) curable or is highly resistant to treatment. 4. Compliance: Participant must understand and be willing, able, and likely to comply with the survey procedures. Participant must be able to understand the questions 5. Consent: Participant has verbally confirmed his/her consent, documented with a cross on the CRF by the investigator. For children and adolescent: the parent has verbally indicated his/her consent, documented with a cross on the CRF by the investigator 6. Affiliation: Participant must be either patient or parent of a patient at the Department of General Paediatrics, Neonatology and Paediatric Cardiology of the University Hospital Düsseldorf Or Participants must be a health care professional (nurse or paediatrician) employed at the Department of General Paediatrics, Neonatology and Paediatric Cardiology of the University Hospital Düsseldorf

Exclusion criteria

Exclusion criteria: For paediatric patients aged 6-<18 y: not fully oriented, e.g. in the post-operative period and not yet fully awoke

Design outcomes

Primary

MeasureTime frame
To identify the maximum amount of 2 mm mini-tablets children aged 6-<12 y and adolescents aged 12-<18 y would be willing to take To identify the maximum amount of 3 mm mini-tablets children aged 6-<12 y and adolescents aged 12-<18 y would be willing to take

Secondary

MeasureTime frame
To identify the maximum amount of 2 mm mini-tablets parents of children aged 0-<2 y and 2-<6 y would be willing to administer To identify the maximum amount of 3 mm mini-tablets parents of children aged 0-<2 y and 2-<6 y would be willing to administer To identify the maximum amount of 2 mm mini-tablets nurses would be willing to administer to paediatric patients aged 0-<2 y, 2-<6 y, 6-<12 y, and 12-<18 y To identify the maximum amount of 3 mm mini-tablets paediatricians would be willing to administer to paediatric patients aged 0-<2 y, 2-<6 y, 6-<12 y, and 12-<18 y

Countries

Germany

Contacts

Public ContactViviane Klingmann

Universitätsklinikum Düsseldorf, Klinik für Allgemeine Pädiatrie, Neonatologie und Kinderkardiologie

viviane.klingmann@med.uni-duesseldorf.de+492118107906

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026